Added to YB: 2026-08-17
Pitch date: 2026-08-13
HIMS [neutral]
Hims & Hers Health, Inc.
-3.43%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$6.6B
Pitch Price
$29.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
806.05
P/E
-45.27
EV/Sales
2.82
Sector
Health Care Providers and Services
Category
growth
$HIMS - Earnings Review Q2 2026
HIMS (earnings): Q2 rev $753M (+38% YoY, beat 4%), EPS ($0.37) missed on $48M legal/M&A costs, GM 64% (-6pts on strategic scaling). EBITDA $60M beat 28%. Record ~300K net adds, 2.9M subs. FY26 rev guide raised to $3.2B (Eucalyptus intl driver), EBITDA cut to $300M. Novo weight-loss strong, peptides awaiting FDA. Stays long.
Read full article (3 min)